Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Want to invest in UK healthcare stocks? Here are some companies I’d look at

Looking for healthcare stocks for your portfolio? You’ll find plenty of options on the London Stock Exchange, says Edward Sheldon.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When it comes to sectors that have long-term growth potential, it’s hard to look past healthcare. An ageing population, rising wealth in emerging markets, and the increasing prevalence of major health issues are dominant structural forces. And they mean demand for healthcare looks set to increase significantly in the years ahead.

In terms of healthcare stocks, British investors have many options. Whether you’re looking to invest in a large-cap FTSE 100 healthcare stock, or an under-the-radar small-cap healthcare stock, there are plenty of investment opportunities. With that in mind, here’s a look at some UK healthcare stocks I believe could be worth checking out if you want to invest in healthcare.

Large-cap healthcare stocks

In the large-cap area of the market (the FTSE 100), there are a number of prominent healthcare stocks. The largest is AstraZeneca. It’s a global, science-led biopharmaceutical company. It specialises in oncology (cancer), cardiovascular and metabolic diseases, and respiratory, inflammation and autoimmune diseases.

Then there’s GlaxoSmithKline. Its area of specialism is pharmaceuticals, vaccines, and consumer healthcare products. Recently, GSK reached an agreement with Pfizer to combine their consumer health businesses. The combined entity will be a market leader in pain relief, digestive health, and therapeutic oral health.

Also in the FTSE 100, there’s Smith & Nephew. It specialises in joint replacement systems and looks set to benefit from the world’s ageing population. And then there’s Hikma Pharmaceuticals, which manufactures branded and non-branded generic medicines.

Mid-caps

In the mid-cap space, there’s a handful of healthcare stocks that could be worth a closer look. One of the larger mid-caps is ConvaTec. It offers products and services in the areas of wound and skincare, ostomy care, continence, and critical care.

Another largish mid-cap healthcare stock is Mediclinic. It’s an international hospital group with operations in a number of companies across the world. Also in the mid-cap area, there’s UDG Healthcare. It provides advisory, communication, and packaging services to the healthcare industry.

Small-caps

In the small-cap area of the market, there are many options if you’re looking for healthcare stocks. I’ll point out, however, that some of these stocks are more speculative in nature. So a cautious approach is sensible.

One small-cap healthcare company that appears to have potential is EMIS. It provides software and information technology services to the healthcare industry. This means it’s a play on both health and technology.

Another smaller company that looks interesting in my opinion is Advanced Medical Solutions. Its area of focus is advanced wound care products and surgical dressings.

There’s also Alliance Pharma, which owns or licenses the rights to over 90 pharmaceutical and consumer healthcare products. It has grown significantly in recent years.

Some other small-cap stocks that could be worth a closer look include clinical trials company Ergomed, antibody specialist Bioventix, and radiology business Medica.

In conclusion, there are many different healthcare stocks listed in the UK. This means that there are plenty of ways to gain exposure to the sector. The key, as always, is to do your own research and diversify your capital across a few companies. This will give you the best chance of profiting from the sector in the long run.

Edward Sheldon owns shares in GlaxoSmithKline and Smith & Nephew. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Advanced Medical Solutions, Alliance Pharma, AstraZeneca, Bioventix, Emis Group, Hikma Pharmaceuticals, and UDG Healthcare. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Tesco employee helping female customer
Growth Shares

Here’s where the experts think the Tesco share price could finish next year

Jon Smith sets his sights on the Tesco share price direction for 2026 and muses over the forecasts being offered…

Read more »

Lady taking a carton of Ben & Jerry's ice cream from a supermarket's freezer
Investing Articles

Should I scoop up some Magnum Ice Cream shares for my ISA? 

The world's largest ice cream business started trading on the London Stock Exchange today. Is this the next buy for…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

2 incredible FTSE 100 shares I can’t stop buying!

Discover the two FTSE 100 shares our writer Royston Wild's been piling into -- and why he expects them to…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing For Beginners

This FTSE 100 share has a P/E ratio less than half the index average! Is it a bargain buy?

Jon Smith points out a FTSE 100 share with a P/E ratio of just 7.37, as he continues his hunt…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Why this FTSE banking gem may hold a lot more value than we think

This FTSE banking giant may be hiding more value than investors expect -- with rising dividends, buybacks, and growth potential…

Read more »

Tesla building with tesla logo and two teslas in front
US Stock

I asked ChatGPT where Tesla stock will be in a year’s time and this is what it said…

Jon Smith got an underwhelming response from ChatGPT regarding Tesla stock's 2026 potential performance, and provides his viewpoint on the…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’ve made this much from 417 shares in this FTSE 100 dividend income gem since 2020…

My £10k investment in this FTSE 100 heavyweight has grown hugely since 2020. With dividends up and the shares still…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Is easyJet a steal at its near-£5 share price after strong 2025 results?

easyJet’s share price has slipped 16% from its peak -- but is this turbulence masking a hidden value gap investors…

Read more »